Quick Answer
Calcium Citrate Absorption Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: A variable degree of carbonation can be seen in stones, and greater carbonate content is associated with culturable microorganisms on the crystal surface, raising the potential need to evaluate for urinary tract infection.Not all laboratories report the presence of carbonated hydroxyapatite or quantify the degree of carbonation.
Key Takeaways
- 01A variable degree of carbonation can be seen in stones, and greater carbonate content is associated with culturable microorganisms on the crystal surface, raising the potential need to evaluate for urinary tract infection.Not all laboratories report the presence of carbonated hydroxyapatite or quantify the degree of carbonation. [Tsai Peihsuan (2026)]
- 02Cohort studies have identified 3 main urinary risk factors associated with CaP stone formation: high urine pH, hypercalciuria, and hypocitraturia(). [Tsai Peihsuan (2026)]
- 03We will next review these clinical risk factors individually and review insights from histopathologic evidence. [Tsai Peihsuan (2026)]
- 04Calcium phosphate (CaP) kidney stones are the second most encountered stone type. [Tsai Peihsuan (2026)]
The current Migaku evidence database contains 2 reusable source documents for Calcium Citrate Absorption Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- A variable degree of carbonation can be seen in stones, and greater carbonate content is associated with culturable microorganisms on the crystal surface, raising the potential need to evaluate for urinary tract infection.Not all laboratories report the presence of carbonated hydroxyapatite or quantify the degree of carbonation. [Tsai Peihsuan (2026); evidence level 3]
- Cohort studies have identified 3 main urinary risk factors associated with CaP stone formation: high urine pH, hypercalciuria, and hypocitraturia(). [Tsai Peihsuan (2026); evidence level 3]
- We will next review these clinical risk factors individually and review insights from histopathologic evidence. [Tsai Peihsuan (2026); evidence level 3]
- Calcium phosphate (CaP) kidney stones are the second most encountered stone type. [Tsai Peihsuan (2026); evidence level 3]
- Reduced kidney function in these patients leads to a range of pathological changes in mineral metabolism termed mineral and bone disorder (MBD)[]. [Ilkun Olesya (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources